Structures by: Kabilan S.
Total: 32
C20H18
C20H18
Organic Chemistry Frontiers (2019) 6, 1 134
a=15.853(3)Å b=12.375(2)Å c=7.3639(12)Å
α=90° β=90° γ=90°
C20H14O4
C20H14O4
Organic Chemistry Frontiers (2019) 6, 1 134
a=8.0844(4)Å b=19.8817(10)Å c=10.2123(5)Å
α=90.00° β=109.061(2)° γ=90.00°
4-[2-(1,3-Dioxoisoindolin-2-yl)-1,3-thiazol-4-yl]benzonitrile
C18H9N3O2S
IUCrData (2016) 1, 7 x161117
a=7.915(7)Å b=12.1641(10)Å c=17.255(14)Å
α=69.51(2)° β=79.50(2)° γ=82.93(3)°
2-[4-(4-Methoxyphenyl)-1,3-thiazol-2-yl]-2,3-dihydro-1<i>H</i>-isoindole-1,3-dione
C18H12N2O3S
IUCrData (2016) 1, 7 x161053
a=7.004(9)Å b=14.054(17)Å c=15.275(19)Å
α=90° β=90.368(12)° γ=90°
2-Chloro-<i>N</i>-[4-(4-chlorophenyl)-1,3-thiazol-2-yl]acetamide
C11H8Cl2N2OS
IUCrData (2016) 1, 6 x160903
a=5.0940(12)Å b=14.738(3)Å c=15.703(3)Å
α=90° β=96.932(9)° γ=90°
2-Chloro-<i>N</i>-(4-phenyl-1,3-thiazol-2-yl)acetamide
C11H9ClN2OS
IUCrData (2016) 1, 6 x160879
a=8.0406(9)Å b=9.2313(14)Å c=15.9898(17)Å
α=85.693(19)° β=76.448(19)° γ=87.082(19)°
4-Chloro-<i>N</i>-(isoquinolin-3-yl)butanamide
C13H13ClN2O
IUCrData (2016) 1, 8 x161290
a=5.263(3)Å b=9.782(5)Å c=12.795(6)Å
α=78.591(9)° β=80.188(7)° γ=74.418(10)°
3-(4-Methoxyphenyl)-4-methyl-<i>N</i>-[4-(4-methylphenyl)-1,3-thiazol-2-yl]benzamide
C25H22N2O2S
IUCrData (2017) 2, 5 x170721
a=9.7840(10)Å b=10.2910(10)Å c=21.58(2)Å
α=90° β=99.528(11)° γ=90°
(<i>E</i>)-<i>N</i>-[(1-Chloro-3,4-dihydronaphthalen-2-yl)methylidene]\ benzohydrazide monohydrate
C18H15ClN2O,H2O
Acta Crystallographica Section E (2020) 76, 2 132-136
a=26.2059(18)Å b=4.8119(3)Å c=12.8084(9)Å
α=90° β=90° γ=90°
3-Methoxy-4-{[5-(4-methoxyphenyl)-1,3,4-oxadiazol-2-yl]methoxy}benzonitrile
C18H15N3O4
Acta Crystallographica Section E (2018) 74, 12 1919-1922
a=6.0847(14)Å b=8.5048(19)Å c=17.286(4)Å
α=102.668(7)° β=90.646(6)° γ=109.813(8)°
<i>N</i>-(4-{[5-(4-Chlorophenyl)-1,3,4-oxadiazol-2-yl]methoxy}phenyl)acetamide
C17H14ClN3O3
Acta Crystallographica Section E (2018) 74, 12 1919-1922
a=42.240(10)Å b=10.233(3)Å c=7.496(2)Å
α=90° β=91.016(11)° γ=90°
1-(2-Chloroacetyl)-3,3-dimethyl-2,6-di-<i>p</i>-tolylpiperidin-4-one
C23H26ClNO2
Acta Crystallographica Section E (2015) 71, 3 o173-o174
a=18.7923(6)Å b=18.8289(5)Å c=11.6689(3)Å
α=90.00° β=93.162(2)° γ=90.00°
1-(2-Chloroacetyl)-2,6-bis(4-fluorophenyl)-3,3-dimethylpiperidin-4-one
C21H20ClF2NO2
Acta Crystallographica Section E (2014) 70, 10 262-264
a=13.5270(3)Å b=10.0150(2)Å c=15.2560(3)Å
α=90.00° β=113.8030(10)° γ=90.00°
2-[4(<i>E</i>)-2,6-Bis(4-chlorophenyl)-3-ethylpiperidin-4-ylidene]acetamide
C21H22Cl2N2O
Acta Crystallographica Section E (2015) 71, 11 o832-o833
a=8.3293(2)Å b=12.2924(3)Å c=19.3226(4)Å
α=90° β=90° γ=90°
2-{2,4-Diphenyl-3-azabicyclo[3.3.1]nonan-9-ylidene}acetonitrile
C22H22N2
Acta Crystallographica Section E (2015) 71, 10 o792-o793
a=7.9672(5)Å b=8.3129(5)Å c=13.6069(8)Å
α=89.607(4)° β=81.886(4)° γ=84.469(4)°
R-2,c-6-Bis(4-bromophenyl)-t-3,t-5-dimethyltetrahydropyran-4-one
C19H18Br2O2
Acta Crystallographica Section E (2007) 63, 11 o4373-o4373
a=15.146(3)Å b=9.1460(18)Å c=26.180(5)Å
α=90.00° β=90.00° γ=90.00°
R-2,c-6-Bis(3-fluorophenyl)t-3,t-5-dimethylpiperidin-4-one
C19H17F2NO
Acta Crystallographica Section E (2007) 63, 12 o4559-o4559
a=22.2891(4)Å b=7.05160(10)Å c=23.4565(4)Å
α=90.00° β=117.711(2)° γ=90.00°
1-Bromoacetyl-2,6-bis(4-methoxyphenyl)-3,5-dimethylpiperidin-4-one
C23H26BrNO4
Acta Crystallographica Section E (2008) 64, 10 o2009-o2010
a=12.9487(9)Å b=25.2882(18)Å c=8.9701(6)Å
α=90.00° β=132.9300(10)° γ=90.00°
R-2,c-6-Bis(4-fluorophenyl)-t-3,t-5-dimethylpiperidin-4-one
C19H19F2NO
Acta Crystallographica Section E (2008) 64, 2 o429-o429
a=7.3830(6)Å b=24.0102(19)Å c=9.4278(7)Å
α=90.00° β=101.7270(10)° γ=90.00°
N-(1-Acetyl-r-7,c-9-diphenyl-4,8-dithia-1,2-diazaspiro[5.4]dec-2-en-3- yl)acetamide
C22H23N3O2S2
Acta Crystallographica Section E (2008) 64, 2 o494-o495
a=12.3310(7)Å b=16.0218(9)Å c=12.3852(7)Å
α=90.00° β=116.7140(10)° γ=90.00°
1-chloroacetyl-3-ethyl-2,6-diphenylpiperidin-4-one oxime
C21H23ClN2O2
Acta Crystallographica Section C (2010) 66, 6 o274-o278
a=34.176(3)Å b=9.1227(9)Å c=12.1235(11)Å
α=90.00° β=91.962(8)° γ=90.00°
1-chloroacetyl-3-ethyl-2,6-diphenylpiperidin-4-one oxime
C21H23ClN2O2
Acta Crystallographica Section C (2010) 66, 6 o274-o278
a=33.849(3)Å b=9.0250(10)Å c=11.9800(10)Å
α=90.00° β=92.510(10)° γ=90.00°
1-chloroacetyl-2,6-diphenyl-3-(propan-2-yl)piperidin-4-one oxime
C22H25ClN2O2
Acta Crystallographica Section C (2010) 66, 6 o274-o278
a=9.4690(10)Å b=16.658(2)Å c=12.653(2)Å
α=90.00° β=90.290(10)° γ=90.00°
2,4-Bis(4-chlorophenyl)-3-azabicyclo[3.3.1]nonan-9-one
C20H19Cl2NO
Acta Crystallographica Section E (2009) 65, 3 o609
a=16.2589(4)Å b=6.8983(2)Å c=18.1291(5)Å
α=90.00° β=116.1490(10)° γ=90.00°
1-chloroacetyl-2,6-bis(2-chlorophenyl)-3,5-dimethyl-piperidin-4-one oxime
C21H21Cl3N2O2
Acta Crystallographica Section E (2010) 66, 6 o1506
a=9.8147(6)Å b=15.5929(11)Å c=13.9498(9)Å
α=90.00° β=93.529(4)° γ=90.00°
1-Chloroacetyl-2,6-bis(2-chlorophenyl)-3,5-dimethylpiperidin-4-one
C21H20Cl3NO2
Acta Crystallographica Section E (2010) 66, 9 o2284
a=11.6295(4)Å b=9.6955(3)Å c=17.4743(5)Å
α=90.00° β=90.4810(10)° γ=90.00°
2-(2,4-Diphenyl-3-azabicyclo[3.3.1]nonan-9-ylidenehydrazono)- 1,3-thiazolidin-4-one
C23H24N4OS
Acta Crystallographica Section E (2009) 65, 3 o584
a=8.3183(3)Å b=10.8435(4)Å c=22.7417(8)Å
α=90.00° β=92.483(2)° γ=90.00°
2,6-Bis(3-fluorophenyl)-3-isopropylpiperidin-4-one
C20H21F2NO
Acta Crystallographica Section E (2010) 66, 7 o1860
a=8.8217(3)Å b=12.7612(4)Å c=30.8613(9)Å
α=90.00° β=91.892(2)° γ=90.00°
Ethyl 4-[2-(3,5-dimethyl-4-oxo-2,6-diphenylpiperidin-1- yl)-2-oxoethyl]piperazine-1-carboxylate
C28H35N3O4
Acta Crystallographica Section E (2011) 67, 3 o541
a=10.9073(3)Å b=19.1940(6)Å c=12.2246(3)Å
α=90.00° β=91.809(2)° γ=90.00°
Bisthiochromanone
C19H12O2S2
Acta Crystallographica Section E (2013) 69, 3 o358
a=11.9480(5)Å b=11.8649(5)Å c=11.1416(5)Å
α=90.00° β=108.918(2)° γ=90.00°
Ethyl 2-[2-(2,4-diphenyl-3-azabicyclo[3.3.1]nonan-9-ylidene)hydrazin-1-yl]-4-methyl-1,3-thiazole-5-carboxylate dimethylformamide monosolvate
C27H30N4O2S,C3H7NO
Acta Crystallographica Section E (2014) 70, 1 o68-o69
a=12.700(5)Å b=19.427(5)Å c=13.203(5)Å
α=90° β=115.249(5)° γ=90°
<i>rac</i>-7-Methyl-3-[(7-methyl-4-oxochroman-3-yl)methyl]-4<i>H</i>-chromen-4-one
C21H18O4
Acta Crystallographica Section E (2013) 69, 5 o763
a=10.664(2)Å b=6.6428(13)Å c=23.754(5)Å
α=90.00° β=91.11(3)° γ=90.00°